Prospects for Chemoprevention of Colorectal Neoplasia
Emerging Role of Anti-Inflammatory Drugs
Seiten
2012
|
2013
Springer Berlin (Verlag)
978-3-642-30330-2 (ISBN)
Springer Berlin (Verlag)
978-3-642-30330-2 (ISBN)
The prevention of colorectal cancer is a subject of increasing medical importance, and there have been a number of promising recent developments. This book examines in detail important aspects of the current status and future prospects for chemoprevention of colorectal tumors. Research into the mechanisms that lead from early colorectal adenoma to colorectal cancer is discussed. The role and modes of action of available drugs such as celecoxib and sulindac are described, and recent data from aspirin trials are analyzed. In addition, the possible impact of nutritional agents with anti-inflammatory properties is considered, and strategies applicable in those with a high level of genetic risk are evaluated. An important feature of the book is its holistic perspective, making it relevant for gastroenterologists, internists, general practitioners, oncologists, colorectal and gastroenterological surgeons, and public health practitioners.
What is chemoprevention today?- Mechanistic aspects in tumor development and progression of colorectal adenoma and carcinoma.- Mode of action of aspirin as a chemopreventive agent.- Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials.- COX-2 active agents in chemoprevention (includes aspirin, coxibs, and DFMO).- New potential developments in aspirin/NSAID derivatives.- Aspirin in CRC chemoprevention in the context of other chronic diseases.- Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal adenoma and carcinoma.- Genetic risks for CRC and hereditary forms of CRC. - Strategies for prevention in high risk population.
From the reviews:
"Part of the Recent Results in Cancer Research series, this multiauthored book examines the emerging role of anti-inflammatory drugs as chemoprevention for colorectal neoplasia. ... The authors wish to provide a multidisciplinary perspective on CRC chemoprevention. ... As such, the book will appeal more to basic science researchers in this area." (Willem J. de Villiers, Doody's Review Service, November, 2012)Erscheint lt. Verlag | 15.8.2012 |
---|---|
Reihe/Serie | Recent Results in Cancer Research |
Zusatzinfo | VIII, 184 p. |
Verlagsort | Berlin |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 424 g |
Themenwelt | Medizinische Fachgebiete ► Chirurgie ► Viszeralchirurgie |
Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie | |
Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Schlagworte | Mechanisms in CRC development • NSAIDs and aspirin • prevention • Public health interest |
ISBN-10 | 3-642-30330-7 / 3642303307 |
ISBN-13 | 978-3-642-30330-2 / 9783642303302 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
58,00 €